PARP1 and glioblastoma: Subsequently, Western blot analysis further indicated that the protein levels of DAPK1, C‐PARP, and C‐Caspase3 were decreased by silencing of DAPK1 in the SC‐treated GBM cells (Figures 4H and S5D).